logo
logo
Search For Features
/
StocksStocks
Intraday BoosterIntraday Booster
Sector BoosterSector Booster
Stock ScreenerStock Screener
Market PulseMarket Pulse
ScreenersScreeners
MoreMore

prime iconGo Prime
My PlansMy Plans
Privacy PolicyPrivacy Policy
ContactContact
Refer & EarnRefer & Earn
ScreenersScreeners
Main
Stock ScreenerStock Screener
Create ScreenerCreate Screener
Explore ScreenersExplore Screeners
Community ScreenersCommunity Screeners
Trading Screeners
CandleSticks ScreenerCandleSticks Screener
Top Gainers & LosersTop Gainers & Losers
Opening Range BreakoutOpening Range Breakout
Stock Screener AIStock Screener AI
Stock Quality ScorecardStock Quality Scorecard
Overvalued StocksOvervalued StocksNew
Undervalued StocksUndervalued StocksNew
Technical Screeners
NR4 StocksNR4 Stocks
NR7 StocksNR7 Stocks
Previous Day High BreakoutPrevious Day High Breakout
Previous Day Low BreakoutPrevious Day Low Breakout
Previous Day Open BreakoutPrevious Day Open Breakout
Bullish Crossover StocksBullish Crossover Stocks
Bearish Crossover StocksBearish Crossover Stocks
High Volume ShockerHigh Volume Shocker
VWAP Breakout StocksVWAP Breakout Stocks
Range High BreakoutRange High Breakout
Range Low BreakoutRange Low Breakout
MoreMore
Markets
Global Market TodayGlobal Market Today
Global IndicesGlobal Indices
Indian IndicesIndian Indices
NIfty TodayNIfty Today
Smart Money
FII DII DataFII DII DataNew
FII BuyingFII Buying
NSE Insider TradingNSE Insider Trading
SLB Stocks DataSLB Stocks Data
Derivatives
FnO MovementsFnO Movements
NSE F&O Lot SizeNSE F&O Lot Size
Ban ListBan List
Analysis & Calendars
Technical DashboardTechnical Dashboard
Sector BoosterSector Booster
Sector AnalysisSector AnalysisNew
Result CalendarResult Calendar
Economic CalendarEconomic Calendar
Balaji Amines Ltd

Balaji Amines

Small Cap1,084 EmployeesIPO 1995
Current Price
1027.40
23.8 (2.37%)Updated
NSE :BALAMINES
BSE :530999
Sector :Chemicals
Today's Range
1010.80
1027.40
union icon
1050.00
52 Week Range
52W Low994.00
52W High1945.00
1027.40
union icon
Downside3.36%
Upside89.31%

Price Chart

Compare with Peers

Historical Ratios

Track top 12 most important financial ratios

P/E Ratio: Price to Earnings - Most used valuation metric

Loading chart...

Analyzing Investment Quality

Processing 9 key metrics...

Key Metrics

Hover for details

Valuation

Market Cap
3,584.68 Cr
Market Cap
Total market value of company
P/E Ratio
24.88
P/E Ratio
Price to Earnings. Lower is generally better (<25 is good)
P/B Ratio
2.39
P/B Ratio
Price to Book Value. <3 may indicate undervaluation
EPS
44.26
EPS
Earnings Per Share. Higher and growing is positive

Profitability

ROE
4.00%
ROE
Return on Equity. >15% is good, >20% is excellent
ROCE
11.00%
ROCE
Return on Capital Employed. >15% is good
Net Margin
10.42%
Net Margin
Net profit as % of revenue. >10% is good
Operating Margin
-%
Operating Margin
Operating profit margin. >15% is good

Growth

EPS Growth (5Y)
8.22%
EPS Growth (5Y)
5-year EPS growth. >15% is strong
Revenue Growth (5Y)
8.34%
Revenue Growth (5Y)
5-year revenue growth. >10% is good
Qtr Sales Growth
-6.86%
Qtr Sales Growth
Quarter-over-quarter sales growth
Qtr Profit Growth
-12.20%
Qtr Profit Growth
Quarter-over-quarter profit growth

Financial Health

Debt/Equity
0.01
Debt/Equity
Financial leverage. <1 is good, <0.5 is excellent
Book Value
569.44
Book Value
Net asset value per share
Dividend Yield
0.99%
Dividend Yield
Annual dividend as % of price. >2% is good
Promoter Holding
54.60%
Promoter Holding
Promoter stake. >50% shows confidence
Good
Average
Needs Attention

SWOT Analysis

Strengths

5 points
  • Remarkably low debt-to-equity ratio (0.01) indicates strong financial health.
  • High promoter holding (54.6%) demonstrates strong management commitment and confidence.

Weaknesses

5 points
  • Quarterly sales declined by -6.86%, signaling potential short-term revenue challenges.
  • Quarterly profit after tax declined by -12.20%, impacting recent profitability.

Opportunities

4 points
  • Growing demand in specialty chemicals sector, especially pharmaceuticals and agrochemicals.
  • Potential for product portfolio diversification into high-margin specialty chemicals.

Threats

4 points
  • Intense competition from domestic and international players may pressure pricing.
  • Volatility in raw material prices poses a significant threat to margins.

Segment-wise Financial Analysis

Financial Results

Balance Sheet

StandaloneAnnualAll amounts in ₹ Crores • CA Schedule III Format

No Balance Sheet Data Available

Standalone annual data is not available for this symbol.
Try switching to Consolidated view.

Shareholding Pattern

Loading shareholding data...

Company Insider Trading Activity

Recent Insider Transactions

Insider NameTransaction DateFiling DateTotal SharesChangePriceAction
Hemanth Reddy Gaddam
12 Mar 202519 Mar 20258.18 L
98,943
₹1,244.2BUY
NOMULA SARITA
18 Mar 202520 Mar 20254.97 L
98,944
₹1,210.05BUY
SMT GADDAM SUSHILA RAJA REDDY FOUNDATION
28 Mar 202529 Mar 202598,944
98,944
₹1,207.15BUY

Corporate Action

Company Announcements

Technical Analysis & Indicators

Standard pivot points - most widely used

Pivot Points (CLASSIC)

LevelPriceDistance% Change
R41126.40+₹99.00+9.64%
R31087.20+₹59.80+5.82%
R21068.60+₹41.20+4.01%
R11048.00+₹20.60+2.01%
PIVOT1029.402.000.19%
CURRENT1027.40--
S1930.40-₹97.00-9.44%
S2969.60-₹57.80-5.63%
S3990.20-₹37.20-3.62%
S41008.80-₹18.60-1.81%
CPR Levels
Support
Resistance
S4
S3
S2
S1
| CPR |
BC: N/AP: N/ATC: N/A
R1
R2
R3
R4
indicator
LTP: N/A
PDH: N/A
PDL: N/A
● Market Sentiment

is trading CPR, indicating

● CPR Width

CPR is

● Opening Range

Day's range: ~

● Price Position

Trading Inside opening range

Delivery Volume Analysis & Trading Activity

Latest Volume
0.59L
(10 Mar 2026)
-19.0% vs avg
Delivery %
49.0%
(10 Mar 2026)
+8.6% vs avg
Avg Volume (20D)
0.73L
(10 Feb - 10 Mar)
20-day average
Avg Delivery %
40.4%
(10 Feb - 10 Mar)
Trend ↑
Delivery % indicates the percentage of traded volume that resulted in actual delivery. Higher delivery % (>50%) suggests genuine buying interest and stronger hands.

Peer Comparison & Industry Benchmarking

Quick Compare

Largest by Market Cap
Asian Paints Ltd
2.34L ₹ Cr
Best Profit Growth
Camlin Fine Sciences Ltd
77.80 %
Highest Dividend Yield
Advanced Enzyme Technologies Ltd
1.75 %

Peer Comparison

Company Name
ACI
Archean Chemical Industries Ltd
ADVENZYMES
Advanced Enzyme Technologies Ltd
ASIANPAINT
Asian Paints Ltd
CAMLINFINE
Camlin Fine Sciences Ltd
CHEMPLASTS
Chemplast Sanmar Ltd
FOSECOIND
Foseco India Ltd
GALAXYSURF
Galaxy Surfactants Ltd
INDIGOPNTS
Indigo Paints Ltd
JUBLCPL
Jubilant Agri & Consumer Products Ltd
LXCHEM
Laxmi Organic Industries Ltd
NEOGEN
Neogen Chemicals Ltd
ROSSARI
Rossari Biotech Ltd
RPEL
Raghav Productivity Enhancers Ltd

About

BALAMINES

Balaji Amines Ltd

Balaji Amines Limited (BAL) is a prominent Indian manufacturer and supplier of methylamines, ethylamines, and a diverse range of specialty chemicals and pharmaceutical excipients. The company's core business revolves around the production and distribution of these crucial chemical compounds, catering to a vast array of industries both domestically and internationally.

BAL's chemical segment is the primary driver of its revenue, focusing on a comprehensive portfolio of products. This includes various methylamines (monomethylamine, dimethylamine, trimethylamine) and ethylamines (monoethylamine, diethylamine, triethylamine), along with derivatives like dimethyl and diethyl amino ethanol. Beyond these foundational chemicals, BAL also produces a wide selection of specialty chemicals such as N-methyl pyrrolidone, morpholine, and others vital to various industrial processes. Furthermore, the company offers a range of pharma excipients, including poly vinyl pyrrolidone, which are essential components in pharmaceutical formulations.

The company's diverse customer base spans a broad spectrum of industries, demonstrating the versatility and importance of its chemical offerings. These industries include pharmaceuticals, agrochemicals, paints and resins, animal feed, oil and gas, rubber cleaning chemicals, dyes and textiles, pesticides and insecticides, water treatment chemicals, optical brighteners, corrosion inhibitors, cosmetics, explosives, and foundry chemicals. This widespread application highlights the strategic importance of BAL's products across various sectors.

In addition to its chemical manufacturing business, BAL operates a secondary segment focused on hospitality. This involves the management and operation of Balaji Sarovar Premiere, a hotel located in Solapur, Maharashtra. While this segment contributes to the company's overall operations, the primary focus and revenue generation remain firmly rooted in its chemical manufacturing and distribution activities.

BAL maintains a significant international presence, exporting its products to a diverse global clientele. Its export markets include the United States, the United Kingdom, Argentina, Latin America, Canada, Israel, Australia, Bangladesh, Germany, Italy, Egypt, South Africa, and other international destinations. This global reach underscores BAL's position as a key player in the international chemical supply chain.

COMPANY FACTS - BALAMINES

Registered Address

Plot No. 47, Balaji Bhawan, Kavuri Hills, Madhapur

Hyderabad

TELANGANA

IN

Company Details

Group: Materials

Sector: Materials

Industry: Chemicals

Exchange: NATIONAL STOCK EXCHANGE OF INDIA

Employees: 1,084

IPO Date: 31/05/1995

MANAGEMENT - BALAMINES

Shri. Ande Reddy

Executive Chairman of the Board

Sri. Ande Reddy

Chief Financial Officer, Whole Time Director

Mr. Abhijeet Kothadiya

Company Secretary and Compliance Officer

Shri. Dundurapu Reddy

Managing Director, Executive Director

Shri. Rajeshwar Nomula

Whole Time Director

Dr. Uma Pradhan

Independent Director

Mr. Mohan Ramakrishna

Independent Director

Mr. Adabala Rao

Independent Director

Dr. Suhasini Shah

Independent Director

Investor Questions Answered

Balaji Amines Ltd (BALAMINES) Stock FAQs

Get answers to the most common questions about Balaji Amines Ltd stock price, fundamentals, financial metrics, and investment analysis

The current share price of Balaji Amines Ltd (BALAMINES) is ₹1,027.4. Today, the stock has gained by ₹23.80 (2.37%), trading in a range of ₹1,010.8 to ₹1,050. The stock opened at ₹1,010.8 with a trading volume of 58,809 shares.
Balaji Amines Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹3,584.68 crores, P/E ratio of 24.88, ROE of 4.00%, and ROCE of 11.00%. The dividend yield stands at 0.99%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
The 52-week high price of Balaji Amines Ltd (BALAMINES) is ₹1,945, while the 52-week low is ₹994. Currently trading at ₹1,027.4, the stock is 3.5% away from its 52-week low and 47.2% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
Whether to buy Balaji Amines Ltd stock at ₹1,027.4 depends on multiple factors. The stock is currently trading with a P/E ratio of 24.88 and P/B ratio of N/A. Today's performance shows a gain of 2.37%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
Balaji Amines Ltd offers a dividend yield of 0.99%, which means for every ₹100 invested at the current price of ₹1,027.4, you can expect to receive approximately ₹0.99 annually as dividends. The face value of the stock is ₹2.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
Balaji Amines Ltd's key financial metrics include: P/E Ratio: 24.88, P/B Ratio: N/A, ROE: 4.00%, ROCE: 11.00%, Dividend Yield: 0.99%, EPS: ₹44.26, Book Value: ₹569.44, Debt-to-Equity: 0.01, and Current Ratio: N/A. The company's market cap stands at ₹3,584.68 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
Balaji Amines Ltd stock opened at ₹1,010.8 and is currently trading at ₹1,027.4, showing a gain of ₹23.80 (2.37%). The intraday high is ₹1,050 and low is ₹1,010.8. The trading volume stands at 58,809 shares, indicating moderate market participation today.
Balaji Amines Ltd has a Price-to-Earnings (P/E) ratio of 24.88, which means investors are willing to pay ₹24.88 for every ₹1 of earnings. With an EPS of ₹44.26, this P/E ratio indicates moderate valuation in line with market standards. Compare this with industry peers and historical P/E ratios for better context.
Balaji Amines Ltd has a market capitalization of ₹3,584.68 crores, making it a small-cap company. Market cap is calculated by multiplying the current stock price (₹1,027.4) by the total number of outstanding shares. This metric helps investors understand the company's size, stability, and investment risk profile.
Balaji Amines Ltd has a book value of ₹569.44 per share and a Price-to-Book (P/B) ratio of N/A. The current market price is ₹1,027.4, which is 80.4% above the book value. A P/B ratio below 1 may indicate undervaluation or asset quality concerns.
Balaji Amines Ltd has a Return on Equity (ROE) of 4.00% and Return on Capital Employed (ROCE) of 11.00%. ROE measures how efficiently the company generates profits from shareholders' equity, while ROCE indicates how well the company uses its capital to generate profits. These returns may need improvement for better profitability. Higher percentages generally indicate better financial performance.
Balaji Amines Ltd operates in the diversified sector and belongs to the general industry. The company competes with other players in this space and its performance is influenced by sector-specific trends, regulatory changes, and market dynamics. Understanding the sector helps investors assess growth potential, cyclical patterns, and industry-specific risks that may impact the stock's performance.
Balaji Amines Ltd has a debt-to-equity ratio of 0.01, which measures the company's financial leverage by comparing total debt to shareholders' equity. A low ratio suggests conservative financing with minimal debt. Lower ratios generally indicate lower financial risk, but optimal levels vary by industry.
Balaji Amines Ltd has an Earnings Per Share (EPS) of ₹44.26, which represents the company's profit allocated to each outstanding share. With a current stock price of ₹1,027.4 and P/E ratio of 24.88, investors are paying 24.88 times the annual earnings per share. This moderate EPS suggests decent earnings generation. Track EPS growth over quarters to assess earnings momentum.
Balaji Amines Ltd has reported a sales growth of N/A% and profit growth of N/A%. The company may be facing growth challenges or operating in a mature market. Consistent growth over multiple quarters is a positive indicator for long-term investors. Compare these growth rates with industry peers for better perspective.
Balaji Amines Ltd has a current ratio of N/A, which measures the company's ability to pay short-term obligations with current assets. A ratio below 1 may indicate potential liquidity concerns. This metric is crucial for assessing the company's working capital management and financial safety.
To analyze Balaji Amines Ltd stock, consider: 1) Fundamental Analysis - Review P/E (24.88), ROE (4.00%), debt-to-equity (0.01), and growth rates. 2) Technical Analysis - Check 52-week range (₹994.00 - ₹1945.00), moving averages, and chart patterns. 3) Valuation - Compare current price (₹1027.40) with book value (₹569.44) and industry peers. 4) Financial Health - Assess current ratio (N/A) and cash flows. 5) Growth Prospects - Evaluate sales growth (N/A%) and profit growth (N/A%). Always diversify and consult a financial advisor.
The face value (or par value) of Balaji Amines Ltd share is ₹2.00. Face value is the nominal value of a share as stated in the company's charter and is used for accounting purposes and calculating dividends. The current market price of ₹1,027.4 is 51270x the face value. Face value remains constant unless the company undergoes a stock split or bonus issue, while market price fluctuates based on demand and supply.
Investing in Balaji Amines Ltd carries several risks: 1) Market Risk - Stock price volatility (52-week range: ₹994.00 - ₹1945.00). 2) Business Risk - Industry-specific challenges in the sector. 3) Financial Risk - Debt-to-equity ratio of 0.01 indicates leverage. 4) Liquidity Risk - Based on trading volume of 58,809 shares. 5) Valuation Risk - P/E of 24.88 may indicate over/undervaluation. 6) Economic Risk - Macroeconomic factors affecting the industry. Diversify your portfolio and invest only what you can afford to lose.
Balaji Amines Ltd operates in the industry with key metrics: P/E ratio of 24.88, ROE of 4.00%, market cap of ₹3,584.68 crores, and dividend yield of 0.99%. To make an informed comparison, analyze these metrics against industry peers considering factors like revenue growth (N/A%), profit margins, debt levels (D/E: 0.01), and market position. Use our peer comparison tool on this page to see detailed side-by-side analysis with competitors.
Target prices for Balaji Amines Ltd vary among analysts and depend on multiple factors including earnings projections, industry trends, and market conditions. The stock is currently trading at ₹1,027.4, with a 52-week range of ₹994.00 to ₹1945.00. Based on fundamentals like P/E (24.88), ROE (4.00%), and growth rates, analysts may have different target prices. Always refer to recent research reports from reputed brokerages and make decisions based on your own analysis and risk appetite.
Consider selling Balaji Amines Ltd stock when: 1) Target Price Achieved - If the stock reaches your predetermined target from current ₹1027.40. 2) Fundamental Deterioration - Declining ROE (currently 4.00%), increasing debt (D/E: 0.01), or falling growth rates. 3) Better Opportunities - Finding stocks with superior risk-reward ratios. 4) Portfolio Rebalancing - When the stock becomes overweight in your portfolio. 5) Changed Investment Thesis - If reasons for buying no longer hold. 6) Stop Loss - If price falls below your risk threshold. Always base decisions on thorough analysis rather than emotions.
Tax implications for Balaji Amines Ltd stock investments: 1) Short-term Capital Gains (STCG) - If sold within 1 year, gains taxed at 15% plus cess. 2) Long-term Capital Gains (LTCG) - If held over 1 year, gains above ₹1 lakh taxed at 10% without indexation. 3) Dividend Income - Dividends (current yield: 0.99%) are taxable as per your income tax slab. 4) Securities Transaction Tax (STT) - Applicable on both buy and sell transactions. 5) Intraday Trading - Treated as speculative income, taxed as per slab. Tax laws change periodically, so consult a tax advisor for personalized guidance and latest regulations.